Semaglutide / Vitamin B12 500 mcg–500 mcg Oral Troches | Compounded GLP-1 Therapy
GLP-1 Receptor Support with Vitamin B12 for Appetite and Metabolic Regulation
This compounded oral strip formulation is designed to support appetite regulation, metabolic balance, and blood sugar management in eligible patients. Compounded GLP-1 receptor therapy works by activating natural pathways involved in satiety signaling, digestion, and metabolic regulation. By slowing gastric emptying and enhancing the body’s natural fullness signals, this treatment may help reduce calorie intake and support medically supervised weight management programs.
Vitamin B12 is included in the formulation to support cellular energy metabolism and nervous system function. Some patients may experience improved energy levels or reduced fatigue while receiving treatment. The oral strip dissolves in the mouth and allows medication absorption through oral tissues for convenient administration.
This oral compounded formulation is prescribed for eligible patients under provider supervision. It is not FDA-approved for safety or efficacy and is not equivalent to brand-name GLP-1 medications. Results may vary. Review important medication safety information.
Important Safety Information: Semaglutide / Vitamin B12 500 mcg–500 mcg Oral Strip | Compounded GLP-1 Therapy
What is this?
This Important Safety Information summarizes key warnings and precautions for Semaglutide combined with Vitamin B12 in a compounded oral strip formulation. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood sugar levels, appetite signaling, and metabolic activity. It is commonly prescribed to support blood sugar control and may also assist with weight management when clinically appropriate. Vitamin B12 is included to support energy metabolism and nerve function and may help reduce fatigue in some individuals. This compounded oral strip formulation is prepared by a licensed compounding pharmacy and has not been reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. Use only as directed by a licensed healthcare provider. This summary does not include all available information. Always read your prescription label and follow your provider’s instructions.
Most Serious Warnings
Semaglutide products may increase the risk of serious adverse events, including:
Possible thyroid tumors, including medullary thyroid carcinoma observed in animal studies
Severe allergic reactions including rash, swelling of the face, lips, tongue, or throat
Pancreatitis (severe inflammation of the pancreas)
Gallbladder disease including gallstones or gallbladder inflammation
Kidney problems or worsening kidney function, especially with dehydration
Do not use this medication if you or a family member have a history of medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Who Should NOT Take Semaglutide
Do not take this medication if you:
Have a known allergy to semaglutide, vitamin B12, or any component of the formulation
Have a personal or family history of medullary thyroid cancer
Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Have been diagnosed with type 1 diabetes unless specifically directed by a provider
Before Taking This Medication, Tell Your Healthcare Provider if You:
Have a history of pancreatitis
Have gallbladder disease or gallstones
Have kidney disease or problems with dehydration
Have diabetic retinopathy or vision problems related to diabetes
Have a history of depression or suicidal thoughts
Are pregnant, planning to become pregnant, or breastfeeding
Take other diabetes medications or drugs that affect blood sugar
Take prescription medications, supplements, or herbal products
Possible Side Effects
Common (mild to moderate):
Nausea or upset stomach
Vomiting or diarrhea
Constipation
Decreased appetite
Abdominal discomfort
Serious (seek medical care immediately):
Severe stomach pain that may spread to the back (possible pancreatitis)
Signs of gallbladder problems such as upper right abdominal pain, fever, or yellowing of the skin or eyes
Severe allergic reaction with swelling, rash, or difficulty breathing
Sudden vision changes
Symptoms of low blood sugar such as dizziness, confusion, shaking, sweating, or rapid heartbeat
While Taking Semaglutide / Vitamin B12
Tell your healthcare provider immediately if you:
Experience persistent vomiting, severe nausea, or dehydration
Develop severe abdominal pain or symptoms of pancreatitis
Notice vision changes or worsening eye symptoms
Experience signs of low blood sugar
Pregnancy and Fertility
Semaglutide may harm an unborn baby. If you are planning to become pregnant, speak with your healthcare provider about discontinuing treatment at least two months before attempting pregnancy.
Missed Dosage
If you miss a dose:
Take the missed dose when you remember unless it is close to your next scheduled dose
Skip the missed dose if it is near the next scheduled dose
Do not double doses
Storage
Store according to the instructions provided by your pharmacy
Protect from excessive heat and moisture
Keep out of reach of children and pets
Medication Disposal
Dispose of unused or expired medication according to local medication disposal guidelines. Contact your pharmacy if you have questions about safe disposal methods.
Provider Oversight and Order Review
This compounded medication requires review and oversight by licensed Superior Health & Wellness providers. Dosing and treatment recommendations may be adjusted based on patient health history, laboratory testing, and treatment goals.
Telemedicine Disclosure
This prescription may be issued through a telemedicine consultation. If you experience severe or concerning symptoms, contact your prescribing provider immediately or seek emergency medical care.
Disclaimer
This summary does not include all information about Semaglutide / Vitamin B12 and should not replace medical guidance. Always consult your healthcare provider or pharmacist for complete safety information, potential interactions, and individualized treatment recommendations. This compounded medication has not been evaluated or approved by the FDA for safety or efficacy.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.